|
13/08/2024
|
07:00
|
Cancellation - Destiny Pharma plc
|
RNS
|
|
12/08/2024
|
07:00
|
Last Day of Dealings on AIM
|
RNS
|
|
05/08/2024
|
11:58
|
Director/PDMR Shareholding
|
RNS
|
|
31/07/2024
|
11:00
|
Result of GM and Cancellation of Trading on AIM
|
RNS
|
|
15/07/2024
|
07:00
|
Proposed Cancellation of Admission to Trading
|
RNS
|
|
20/06/2024
|
07:00
|
Exercise of Options and Total Voting Rights
|
RNS
|
|
18/06/2024
|
07:00
|
Efficacy of XF-70 in Fungal Skin Infections
|
RNS
|
|
12/06/2024
|
12:16
|
Result of Annual General Meeting
|
RNS
|
|
12/06/2024
|
11:00
|
2024 Annual General Meeting and Statement
|
RNS
|
|
11/06/2024
|
07:00
|
Destiny Pharma's XF-73 Nasal Awarded MHRA ILAP
|
RNS
|
|
24/05/2024
|
07:00
|
Exercise of Options and Total Voting Rights
|
RNS
|
|
09/05/2024
|
14:35
|
Posting of Annual Report and Notice of AGM
|
RNS
|
|
25/04/2024
|
07:00
|
Full year results and review of strategic options
|
RNS
|
|
08/04/2024
|
07:00
|
Notice of Full Year Results
|
RNS
|
|
19/03/2024
|
14:47
|
Exercise of Options and Total Voting Rights
|
RNS
|
|
31/01/2024
|
07:00
|
Clinical development update
|
RNS
|
|
22/01/2024
|
07:00
|
Appointment of Nominated Adviser and Sole Broker
|
RNS
|
|
04/01/2024
|
07:00
|
Year End Business Update
|
RNS
|
|
20/10/2023
|
07:00
|
Grant of Share Options
|
RNS
|
|
19/10/2023
|
07:00
|
Director/PDMR Shareholding
|
RNS
|
|
17/10/2023
|
07:01
|
XF Pipeline Update Meeting
|
RNS
|
|
17/10/2023
|
07:00
|
Publication of new microbiological data for XF-73
|
RNS
|
|
10/10/2023
|
07:00
|
Director/PDMR Shareholding
|
RNS
|
|
04/10/2023
|
12:34
|
Director/PDMR Shareholding
|
RNS
|
|
27/09/2023
|
07:00
|
Notice of XF Pipeline Update Meeting
|
RNS
|
|
20/09/2023
|
07:00
|
Interim Results
|
RNS
|
|
23/08/2023
|
07:00
|
Notice of Interim Results
|
RNS
|
|
31/07/2023
|
12:01
|
Publication of new data for XF-73
|
RNS
|
|
25/07/2023
|
07:00
|
Appointment of new Chairman
|
RNS
|
|
19/07/2023
|
12:55
|
Board changes including appointment of new CEO
|
RNS
|
|
07/07/2023
|
07:00
|
Exercise of Options and Total Voting Rights
|
RNS
|
|
29/06/2023
|
07:00
|
Business Update
|
RNS
|
|
26/05/2023
|
15:27
|
Director/PDMR Shareholding
|
RNS
|
|
26/05/2023
|
07:00
|
Director Dealing
|
RNS
|
|
25/05/2023
|
12:23
|
Result of Annual General Meeting
|
RNS
|
|
25/05/2023
|
07:00
|
Dr Debra Barker Appointed Interim CEO
|
RNS
|
|
12/05/2023
|
12:24
|
Grant of Share Options
|
RNS
|
|
02/05/2023
|
07:00
|
Positive results from SPOR-COV® research
|
RNS
|
|
26/04/2023
|
16:10
|
Posting of Annual Report and Notice of AGM
|
RNS
|
|
26/04/2023
|
10:05
|
Exercise of Options and Total Voting Rights
|
RNS
|
|
13/04/2023
|
07:00
|
Audited results for year ended 31 December 2022
|
RNS
|
|
04/04/2023
|
07:00
|
Landmark data published on NTCD-M3
|
RNS
|
|
03/04/2023
|
07:00
|
Notice of Results and Investor Presentation
|
RNS
|
|
24/03/2023
|
07:00
|
Landmark XF-73 Phase 2 data published in journal
|
RNS
|
|
16/03/2023
|
15:29
|
Result of General Meeting and Total Voting Rights
|
RNS
|
|
15/03/2023
|
16:02
|
Result of Open Offer
|
RNS
|
|
06/03/2023
|
10:50
|
Exercise of Options and Total Voting Rights
|
RNS
|
|
06/03/2023
|
10:31
|
Holding(s) in Company
|
RNS
|
|
28/02/2023
|
15:55
|
Posting of Circular and Notice of General Meeting
|
RNS
|
|
27/02/2023
|
16:30
|
Director/PDMR Shareholding
|
RNS
|